Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02078037 · ClinicalTrials.gov registry record · Early Phase 1
Systemic Normothermia in Intracerebral Hemorrhage (ICH)
A Early Phase 1 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT02078037 is a Early Phase 1 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 9 participants.
The verdict
NCT02078037, a Early Phase 1 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Patients with a supratentorial intracerebral hemorrhage will be randomly assigned to either the experimental group which will keep them at a normal body temperature or the standard of care group. The investigators propose to test the hypothesis that prophylactic forced normothermia in patients with ICH leads to less systemic inflammation and decreased perihematomal edema.
Interventions
- OTHER Standard of Care
- DEVICE Arctic Sun cooling device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02078037
The ClinicalTrials.gov registry entry for NCT02078037 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT02078037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02078037 about?
NCT02078037 is a clinical study titled "Systemic Normothermia in Intracerebral Hemorrhage (ICH)". Patients with a supratentorial intracerebral hemorrhage will be randomly assigned to either the experimental group which will keep them at a normal body temperature or the standard of care group. The investigators propose to test the hypothesis that prophylactic forced normothermia in patients with ...
What is the current status of trial NCT02078037?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2014-03. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02078037?
The interventions under investigation include: Standard of Care (OTHER), Arctic Sun cooling device (DEVICE).
Who is sponsoring clinical trial NCT02078037?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.